Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This study aims to investigate the effects of a nutritional intervention with selenium-biofortified strawberries on glucose homeostasis and hepatic function of healthy individuals. The study will assess if consumption of selenium-biofortified strawberries would increase the selenium endogenous concentration (primary outcome) and if it would impact, and to which extension, glucose homeostasis and hepatic function (secondary outcome).
Selenium is an essential micronutrient with antioxidant properties and a crucial role in various physiological processes. Biofortification of crops with selenium offers a promising strategy to enhance selenium intake and improve human health. Strawberries are a widely consumed fruit and can serve as an effective vehicle for selenium delivery. The effects of consuming selenium-biofortified strawberries on human health will be investigated.
3. Study Goals and Objectives
The primary objective is to evaluate the impact of consuming selenium-biofortified strawberries for 30 days on serum selenium concentration in healthy adults. The secondary objective is to assess the influence of this intervention on glucose profile and hepatic function. • Fifty-five healthy adult volunteers (both sexes) will be randomly assigned to three groups:
Control group: Consuming 100 grams of control strawberries daily.
Intervention group (selenium-biofortified strawberries): Consuming 100 grams of selenium-biofortified strawberries daily.
Intervention group (selenium supplement): Consuming a selenium supplement of 100 micrograms daily.
Selenium.
Glucose
Insulin
insulin resistance
insulin sensitivity
β-cell function
aminotransferase (AST)
alanine aminotransferase (ALT)
gamma-glutamyl transferase (GGT)
albumin (ALB)
The statistical analyses will be carried out using specific software. To compare the baseline characteristics of the groups student t tests will be used. The comparison between the different groups of participants and within the same group between baseline and T30 will be carried out using One-Way ANOVA followed by Sidak test. Values will be expressed as mean ± standard deviation (mean ± SD). P-value ≤ 0.05 will be considered to be statistically significant.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Control group | Placebo Comparator | The control group received strawberries (control strawberries 100grams/day) that was without biofortification with the same characteristic of strawberries lettuce(soil, water, harvesting time) for 30 days |
|
| Selenium-biofortified strawberry supplementation | Active Comparator | This group will received selenium biofortified strawberries (100grams/day) with the same characteristic of control strawberries lettuce(soil, water, harvesting time) for 30 days |
|
| Tablet Selenium supplementation | Active Comparator | This group will received selenium in tablet (100 micrograms/day) for 30 days |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| supplementation with control strawberry | Dietary Supplement | control strawberry supplementation (100 grams/day) for 30 days |
|
| Measure | Description | Time Frame |
|---|---|---|
| Measurement of selenium concentration in participants | Selenium (μg/L) will be measured in serum at baseline and after 30 days | 30 days |
| Measure | Description | Time Frame |
|---|---|---|
| Measurement of glucose in participants | Glucose (mg/dL) will be measured in serum at baseline and after 30 days | 30 days |
| Measurement of insulin in participants | Insulin (mUI/L) will be measured in serum at baseline and after 30 days |
| Measure | Description | Time Frame |
|---|---|---|
| Measurement of Height in participants | Height (meters) will be assessed at baseline | baseline |
| Measurement of body weight in participants | Body weight (kg) will be assessed at baseline and after 30 days |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Sara Baldassano | NABbio, STEBICEF department Palermo, Italy, 90128 | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Biological, Chemical and Pharmaceutical Sciences and Technologies, Palermo University | Palermo | PA | 90141 | Italy |
Not provided
| ID | Term |
|---|---|
| D019587 | Dietary Supplements |
| D012643 | Selenium |
| D013607 | Tablets |
| ID | Term |
|---|---|
| D005502 | Food |
| D000066888 | Diet, Food, and Nutrition |
| D010829 | Physiological Phenomena |
| D019602 | Food and Beverages |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| supplementation with biofortified strawberry | Dietary Supplement | selenium biofortified strawberry supplementation (100 grams/day) for 30 days |
|
| supplementation with selenium in tablet | Dietary Supplement | selenium supplementation in tablet (100 micrograms/day) for 30 days |
|
| 30 days |
| Measurement of insulin resistance in participants | Insulin resistance (HOMA-IR) will be calculated from fasting glucose and insulin levels at baseline and after 30 days | 30 days |
| Measurement of insulin sensitivity in participants | Insulin sensitivity (QUICKI) will be calculated from fasting glucose and insulin levels at baseline and after 30 days | 30 days |
| Measurement of β-cell function in participants | β-cell function (HOMA-β) will be calculated from fasting glucose and insulin levels at baseline and after 30 days | 30 days |
| Measurement of aminotransferase (AST) in participants | AST (U/L) will be measured in serum at baseline and after 30 daysbaseline and after 30 days | 30 days |
| Measurement of alanine aminotransferase (ALT) in participants | ALT (U/L) will be measured in serum at baseline and after 30 days | 30 days |
| Measurement of gamma-glutamyl transferase (GGT) in participants | GGT (U/L) will be measured in serum at baseline and after 30 days | 30 days |
| Measurement of albumin (ALB) in participants | ALB (g/dL) will be measured in serum at baseline and after 30 days | 30 days |
| 30 days |
| Measurement of body mass index (BMI) in participants | Weight in kilograms, height in meters will be aggregated to arrive at one reported value (weight and height will be combined to report BMI in kg/m²) | 30 days |
| Measurement of body composition in participants | Lean mass as percent of body weight and fat mass as percent of body weight will be assessed at baseline and after 30 days | 30 days |
| D018011 |
| Chalcogens |
| D004602 | Elements |
| D007287 | Inorganic Chemicals |
| D008903 | Minerals |
| D004304 | Dosage Forms |
| D004364 | Pharmaceutical Preparations |